Gyre Therapeutics, Inc. GYRE Gyre — General And Administrative Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s gyre — general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s gyre — general and administrative expense?
- Gyre Therapeutics, Inc. (GYRE) reported gyre — general and administrative expense of $2.46M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s gyre — general and administrative expense changed year-over-year?
- Gyre Therapeutics, Inc.'s gyre — general and administrative expense increased by 76.0% year-over-year, from $1.4M to $2.46M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s gyre — general and administrative expense?
- Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s gyre — general and administrative expense has grown at a 18.3% compound annual growth rate (CAGR), from $5.21M to $7.29M.
- What does gyre — general and administrative expense mean?
- This includes the overhead costs required to support the segment's operations, such as executive salaries, legal fees, office rent, and other corporate support functions. It represents the fixed cost base necessary to maintain the business infrastructure. Investors monitor this to assess the company's operational discipline and scalability.